Amgen, Inc. (AMGN)
369.48
+1.88
(+0.51%)
USD |
NASDAQ |
Mar 06, 16:00
369.47
-0.01
(-0.00%)
After-Hours: 20:00
Amgen Market Cap : 199.17B for March 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 178.74B |
| Johnson & Johnson | 579.46B |
| Eli Lilly & Co. | 933.45B |
| Merck & Co., Inc. | 286.28B |
| Regeneron Pharmaceuticals, Inc. | 80.28B |
Market Cap Related Metrics
| PE Ratio | 25.96 |
| PS Ratio | 5.448 |
| PEG Ratio | 0.2930 |
| Price to Book Value | 23.00 |
| Price to Free Cash Flow | 24.71 |
| Price | 369.48 |
| Earnings Yield | 3.85% |
| PEGY Ratio | 0.2845 |
| Operating PE Ratio | 19.51 |
| Normalized PE Ratio | 23.50 |